Residual triamcinolone acetonide in the macular hole after vitrectomy.
OBJECTIVE
To report a case of vitrectomy using intraocular triamcinolone acetonide (TA), in which TA remained in the macular hole after surgery.


METHODS
Observational case report.


METHODS
A 60-year-old Japanese man had a Stage II macular hole in the right eye with best-corrected visual acuity of 20/50. A pars plana vitrectomy using TA was performed. Visual acuity and anatomic results were followed up for a period of 8 weeks.


RESULTS
On the sixth postoperative day, residual TA deposition was observed in the macular hole. On the 14th postoperative day, no residual TA was found and the macular hole was successfully closed. The best-corrected visual acuity of the right eye improved to 20/15.


CONCLUSIONS
Residual TA in the macular hole after vitrectomy did not interfere with macular hole repair either anatomically or functionally.
Takeuchi
Masaru
M
Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan. takeuchi@tokyo-med.ac.jp
Katagiri
Yoshiaki
Y
Usui
Masahiko
M
D003131:Combined Modality Therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000187:drug effects* / Q000473:pathology; D012167:Retinal Perforations / Q000175:diagnosis / Q000628:therapy*; D012449:Safety; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014821:Vitrectomy
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide